| 前收市價 | 1.1800 |
| 開市 | 1.1900 |
| 買盤 | 1.2600 x 5300 |
| 賣出價 | 1.2900 x 5300 |
| 今日波幅 | 1.1900 - 1.3100 |
| 52 週波幅 | 0.3450 - 2.1050 |
| 成交量 | |
| 平均成交量 | 9,328,555 |
| 市值 | 329.376M |
| Beta 值 (5 年，每月) | 3.74 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -0.2600 |
| 業績公佈日 | 2024年5月03日 - 2024年5月07日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 5.67 |
ZacksOcugen (OCGN) to Report Q1 Earnings: What's in the Cards?
Ocugen (OCGN) is expected to provide updates regarding the developmental program of its lead candidate, OCU400, for two rare retinal diseases in the first-quarter earnings release.
ZacksOcugen (OCGN) Up as DSMB Allows Cohort 2 Dosing in GA Study
Ocugen (OCGN) stock gains as the DSMB for the phase I/II study of OCU410 approves the initiation of dosing with the medium dose of OCU410 in the dose-escalation phase of the GA study.
Motley FoolOcugen (OCGN) Q4 2023 Earnings Call Transcript
OCGN earnings call for the period ending March 31, 2024.
